Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Leukemia
Surveillance Scanning in Transformed Indolent Lymphoma Is of Limited Clinical Benefit
Leukemia
Read More ›
Peripheral T-Cell Lymphoma Represents High Clinical Burden, Resource Utilization, and Costs
Leukemia
Read More ›
Idelalisib Improves Outcomes in Heavily Pretreated CLL Patients
Leukemia
Read More ›
Ph+ CML: Deep Molecular Response Achieved and Sustained More Often With Nilotinib
Leukemia
Read More ›
Anti-CD20 Agent Improves Outcomes in Elderly/Unfit Patients With Chronic Lymphocytic Leukemia
Leukemia
Read More ›
Novel Anti-CD20 Antibody Superior to Rituximab on Progression-Free Survival in Unfit CLL Patients
Leukemia
Read More ›
Genomics of Acute Myeloid Leukemia Explored
Leukemia
Read More ›
Ponatinib Given Early May Stem Resistance in CML
By
Alice Goodman
Leukemia
Read More ›
First-in-Class PI3K Inhibitor Shows Remarkable Phase 1 Results in CLL
By
Alice Goodman
Leukemia
Read More ›
Safety of Bendamustine in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
By
Julie M. Vose, MD, MBA
Leukemia
Read More ›
Page 3 of 4
1
2
3
4